A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervix.

Eriko Takatori,Tadahiro Shoji,Yasuko Suga,Hanae Niinuma,Yuki Miura,Yoshitaka Kaido,Anna Takada,Masahiro Kagabu,Satoshi Takeuchi,Toru Sugiyama

A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervix.

2014

Eriko Takatori
Tadahiro Shoji
Yasuko Suga
Hanae Niinuma
Yuki Miura
Yoshitaka Kaido
Anna Takada
Masahiro Kagabu
Satoshi Takeuchi
Toru Sugiyama

Background The efficacy and safety of S-1/oxaliplatin (SOX) therapy in patients with recurrent adenocarcinoma of the uterine cervix were examined in a pilot study.

Keywords:

Oxaliplatin
Cervical adenocarcinoma
Oncology
Cervix
General surgery
Adenocarcinoma
Medicine
Internal medicine
Chemotherapy
in patient
Surgical oncology
uterine cervix
second line chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations